VVUS 3.05 Vivus Inc $VVUS Hit a 52 week low of 2.97 Closing

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
VVUS 3.05 Vivus Inc $VVUS Hit a 52 week low of 2.97 Closing the day 10:44 at 3.05 +0.01 +0.33% With a day low of 2.97 and a total volume of 506,438.

VVUS Recent Posts: http://investorshangout.com/VIVUS-Inc-VVUS-55858/

VVUS Vivus Inc Recent Headline News

Why VIVUS (VVUS) Might Be a Diamond in the Rough - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 41 mins ago
VIVUS is well-equipped to bounce down the road with solid estimate revisions and an impressive Zacks Rank and looks well positioned for a solid gain
VVUS: 3.05 (+0.01)

Janssen Is Working Its Way Toward Anti-Obesity
Spencer Osborne - at Seeking Alpha - Mon Nov 17, 4:14PM CST

ZFGN: 20.34 (-0.31), OREX: 5.56 (-0.06), NVO: 44.74 (+0.52), VVUS: 3.05 (+0.01), ARNA: 4.14 (-0.17)

EnteroMedics May Enter The Obesity Space - What Does It Mean?
Spencer Osborne - at Seeking Alpha - Mon Nov 17, 3:43PM CST

OREX: 5.56 (-0.06), ETRM: 1.31 (+0.01), VVUS: 3.05 (+0.01), ARNA: 4.14 (-0.17)

For This Obesity Drug, Europe Trumps the U.S.
Brian Orelli, The Motley Fool - Motley Fool - Mon Nov 17, 3:00PM CST
The launch of Orexigen Therapeutics ' obesity drug Contrave isn't off to the best start. As Chief Commercial Officer Mark Booth put it during the company's latest conference call: Unfortunately, like many new tactics, there have been some...
OREX: 5.55 (-0.07), VVUS: 3.05 (+0.01), ARNA: 4.14 (-0.17)

ARNA Management And Investors Underestimating The Potential Of Belviq And Phentermine Combination
Lance Brofman - at Seeking Alpha - Thu Nov 13, 8:52AM CST

OREX: 5.55 (-0.07), HLF: 38.59 (+0.27), NVO: 44.74 (+0.52), VVUS: 3.05 (+0.01), AMGN: 162.38 (+0.14), GSK: 46.22 (-0.06), ARNA: 4.14 (-0.17)

Critical Alerts For American Eagle Outfitters, Novartis, VIVUS, King Digital and Canadian Solar Released By InvestorsObserver
PR Newswire - Thu Nov 13, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for AEO, NVS, VVUS, KING and CSIQ.
AEO: 13.22 (-0.04), VVUS: 3.05 (+0.01), CSIQ: 26.85 (-0.51), KING: 15.88 (-0.22), NVS: 95.59 (+0.01)

Bel-Phen Pilot Study News, Hold On To Your Shares
Rx Stocks - at Seeking Alpha - Tue Nov 11, 12:13PM CST

OREX: 5.55 (-0.07), VVUS: 3.05 (+0.01), ARNA: 4.14 (-0.17)

Orexigen Turns Around with Q3 Earnings Beat, Shares Soar - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 10:20AM CST
Orexigen (OREX) swung to profit in the third quarter of 2014 with earnings of 9 cents per share beating the Zacks Consensus Estimate of 5 cents.
OREX: 5.55 (-0.07), VVUS: 3.05 (+0.01), AMAG: 35.49 (+0.15)

Can Arena Pharmaceuticals Inc. Overcome Belviq's Slow Launch?
George Budwell, The Motley Fool - Motley Fool - Tue Nov 11, 10:15AM CST
The new generation of diet pills approved by the Food and Drug Administration have stumbled out of the gate. Specifically,  Arena Pharmaceuticals '   Belviq and  VIVUS 's   Qsymia reported a combined 283,000 prescriptions in the third quarter, with...
PFE: 30.39 (-0.20), VVUS: 3.05 (+0.01), GSK: 46.22 (-0.06), ARNA: 4.14 (-0.17)

Why Orexigen Therapeutics, Inc. Stock Skyrocketed
Sean Williams, The Motley Fool - Motley Fool - Mon Nov 10, 5:52PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Orexigen Therapeutics , a...
OREX: 5.55 (-0.07), VVUS: 3.05 (+0.01), ARNA: 4.14 (-0.17)

Arena And Vivus Investors Need To Watch Orexigen
Spencer Osborne - at Seeking Alpha - Mon Nov 10, 12:24PM CST

OREX: 5.55 (-0.07), VVUS: 3.05 (+0.01), ARNA: 4.14 (-0.17)

Orexigen rises as weight loss drug review proceeds
AP - Mon Nov 10, 10:02AM CST
NEW YORK (AP) — Shares of Orexigen Therapeutics Inc. jumped Monday after the company said a European Union review of its weight loss drug Contrave, which was approved in the U.S. in September, is progressing on schedule.
OREX: 5.55 (-0.07), VVUS: 3.05 (+0.01), ARNA: 4.14 (-0.17)

3 Crashing Stocks: Is 1 a Buy?
Motley Fool Staff - Motley Fool - Sun Nov 09, 10:45AM CST
Even though the overall stock market is very close to its record highs, many stocks have not fared so well. In fact, some stocks have gotten crushed recently. We asked three of our analysts to give their opinions on stocks that have been beaten...
VVUS: 3.05 (+0.01), SNY: 48.16 (-0.20), GNW: 9.24 (-0.12), REGN: 417.86 (+4.64)

Belviq Sales Dip Slightly - Quarter Is Flat Thus Far
Spencer Osborne - at Seeking Alpha - Fri Nov 07, 12:02PM CST

VVUS: 3.05 (+0.01), ARNA: 4.14 (-0.17)

VIVUS Posts Narrower-than-Expected Q3 Loss, Revenues Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 3:45PM CST
VIVUS Inc.'s (VVUS) third-quarter 2014 loss of 11 cents per share was much narrower than the Zacks Consensus Estimate of a loss of 21 cents.
AUXL: 32.90 (+0.21), VVUS: 3.05 (+0.01), AMAG: 35.49 (+0.15), SNY: 48.16 (-0.20)

Vivus Beats The Street On Milestone Payment For ED Drug
Spencer Osborne - at Seeking Alpha - Thu Nov 06, 7:59AM CST

OREX: 5.55 (-0.07), VVUS: 3.05 (+0.01), ARNA: 4.14 (-0.17)

Will Belviq Advertising Pick Up Again?
Spencer Osborne - at Seeking Alpha - Thu Nov 06, 7:55AM CST

VVUS: 3.05 (+0.01), ARNA: 4.14 (-0.17)

VIVUS' (VVUS) CEO Seth Fischer on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 6:18PM CST

VVUS: 3.06 (+0.02)

Vivus tops Street 3Q forecasts
Automated Insights - Wed Nov 05, 4:45PM CST
MOUNTAIN VIEW, Calif. (AP) _ Vivus Inc. (VVUS) on Wednesday reported a third-quarter loss of $15.8 million.
VVUS: 3.06 (+0.02)

Vivus Q3 revenues up 24%
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 3:29PM CST

VVUS: 3.06 (+0.02)

VIVUS, Inc. (VVUSQ) Stock Research Links

VVUSQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ouma Connect Streamlines Surrogacy Medical Clearance

Updated Category News Views 177

A Game Changer for Surrogacy Agencies When we talk about innovation, we often focus on the flashiest tech in finance or the buzz of a scorching hot stock. But here's Ouma Health, shifting gears in a sector many traders don't blink at—surrogacy. They're unveiling Ouma Connect, a portal pulling back the curtain on medical clearances for gestational-carrier candidates....

Continue Reading
Mission Bancorp Hits Record Earnings, Extends Buyback

Updated Category News Views 0

Record-Breaking Quarter Amid Challenging Times When Mission Bancorp's earnings hit the tape today, the numbers were enough to catch anyone's eye—$9.2 million in net income for Q3 2026, a 6% increase from last year. That's not small potatoes, especially considering the economic fog we're navigating through. AJ Antongiovanni, holding the reins as CEO, credits the bank's...

Continue Reading
Ernesta Expands Southeast Reach with Atlanta Showroom

Updated Category News Views 85

Ernesta's Southeast Play: The Atlanta Showroom Here's something to turn heads in the world of custom home design—Ernesta has just set up shop in Atlanta, a move that speaks volumes about their ambitions in the Southeast market. This isn't just about selling a few more rugs; it's a calculated step into a region ripe with design potential and a hunger for bespoke home...

Continue Reading
SoftwareOne Secures Leadership in Gartner Report Again

Updated Category News Views 0

A Glance at SoftwareOne's Unyielding Dominance Call it a streak, call it consistency—either way, SoftwareOne's nailed it yet again, bagging the Leader spot in Gartner's Magic Quadrant for SAM Managed Services for the seventh straight year. Yep, seven years running. This ain't just a piece of paper to hang on the office wall. It's a testament to their grit in helping...

Continue Reading
Bank of America Faces Legal Battle Over Compliance Failures

Updated Category News Views 61

Another Day, Another Lawsuit Just when you thought the financial waters were calm, there's a storm brewing for Bank of America Corp. (NYSE: BAC). They've been slapped with a securities class action lawsuit that screams all kinds of regulatory and compliance failures. You’d think with all that cash flow, BAC could afford to run a tight ship. But apparently, they decided...

Continue Reading
Fulcra Unveils DIY Web App Tool for AI Agent Users

Updated Category News Views 52

Fulcra Dynamics Pushes the Boundaries with New Tool There's always that moment when a company nudges the needle, and Fulcra Dynamics seems to have done just that with its latest release. They've unveiled an ingenious tool that promises a shake-up in how we build and use web applications with AI. It's the kind of move that makes you stop and wonder if we're witnessing the...

Continue Reading
Mesirow Expands Retirement Reach with flexPATH Deal

Updated Category News Views 164

Retirement Industry Shake-Up Here's the scoop: Mesirow's swinging big in the retirement scene with its latest acquisition of flexPATH's plan-level 3(38) business. In the world of outsourced fiduciarity—for thems ain't in the know—that's like bolting a turbocharger to an already darn good engine. Mesirow might just be strapping itself in for a wild ride in this 2026...

Continue Reading
BETR Faces Shareholder Suit After Plummeting Stock

Updated Category News Views 29

Better Home & Finance Navigates Turbulent Waters Not every day the news comes up smelling of roses, and that's putting it lightly for Better Home & Finance, trading as NASDAQ: BETR. When you're talking about a splash that sends shockwaves, losing over 28% of your stock value on a single trading day is one whale of a splash indeed. The Numbers That Shook the Waters It's no...

Continue Reading
CSQR Faces Scrutiny Over Cash Flow Discrepancies

Updated Category News Views 63

Dalrymple's Short Report Shakes Csquare's Core Csquare, Inc. (NYSE: CSQR) is reeling from a one-two punch: a damning short report by Dalrymple Finance and an 11.8% share tumble. The timing of this financial body blow, coinciding with Csquare's discordant cash flow claims, could mark the beginning of a long battle for investor trust. This ain't the first time the markets...

Continue Reading
New PGCE Aims to Boost Confidence in Private Tutoring

Updated Category News Views 19

Shifting the Landscape of Private Tutoring Here's a turn of events: parents now have a new tool at their disposal to vet private tutors. The recently unveiled PGCE Tutoring by UWE Bristol aims to provide an added layer of confidence for families navigating the private tutoring market. Breaking the Myth of Tutor Qualifications Did you know a whopping 54% of UK adults think...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating 10 Years of Science and Humanity with STARMUS

Updated Category News Views 94

STARMUS Celebrates a Milestone in Science and Humanity In the heart of London, a significant milestone was marked by the board members of the renowned science and music festival STARMUS. This gathering brought together notable individuals such as Garik Israelian, Sir Brian May, and Peter Gabriel, along with Jane Goodall's family and Vice President of the Jane Goodall...

Continue Reading
Fighting for Rights: Charter Challenge Against Bill 7

Updated Category News Views 154

Overview of the Charter Challenge The Ontario Health Coalition is set to hold a media event to address the ongoing Charter Challenge related to Bill 7, known as the More Beds, Better Care Act. This legislation, introduced by the Ford government, has serious implications for the rights of elderly patients. The upcoming court hearing seeks to highlight the significant...

Continue Reading
The Incredible Growth of Pure Storage Over Five Years

Updated Category News Views 142

Understanding Pure Storage's Exceptional Growth Pure Storage (NASDAQ: PSTG) has truly made a mark in the tech industry over the past five years, significantly outperforming the general market by an impressive 13.35% annually. This translates to an average return of 27.06% per year, a remarkable feat that showcases the company's robust business model and innovative...

Continue Reading
HashKey Global Partners with VerifyVASP for Travel Rule Compliance

Updated Category News Views 487

HashKey Global Enhances Compliance Through Strategic Partnership In an effort to bolster regulatory compliance across its international exchange network, HashKey Global has joined forces with VerifyVASP, a recognized provider of Travel Rule solutions. This strategic partnership will empower HashKey to implement robust compliance measures, ensuring their platforms adhere...

Continue Reading
Partnership to Transform AI Infrastructure for Global Reach

Updated Category News Views 117

Revolutionizing AI Infrastructure Collaboration Armada and Nscale have recently signed a letter of intent to deliver advanced AI infrastructure tailored for both the public sector and enterprise customers on a global scale. This strategic alliance combines the strengths of Nscale, a leading European builder of AI infrastructure known for its impressive supercomputing...

Continue Reading